Evidence map›Paper›PMID 9316886›Full record

ArticleJournal of clinical microbiology1997

Comparative evaluation of use of cna, fnbA, fnbB, and hlb for genomic fingerprinting in the epidemiological typing of Staphylococcus aureus.

M S Smeltzer, A F Gillaspy, F L Pratt, M D Thames

Abstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M S SmeltzerDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205, USA. smeltzermarks@exchange.uams.edu
A F Gillaspy
F L Pratt
M D Thames

Funding

ADHESINS AND STAPHYLOCOCCAL OSTEOMYELITISR29AI037729 · NIAID · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI SMELTZER, MARK S · 1996 to 2000
$111k
PROGRAM FOR THE STUDY OF OPPORTUNISTIC INFECTIONSP20RR011815 · NCRR · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI RANK, ROGER G · 1996 to 1998
–
NCRR NIH HHS P20-RR11815NIAID NIH HHS R29-AI37729
6 · The paper itself

Abstract

We used a genomic fingerprinting protocol to characterize 59 Staphylococcus aureus strains and a single S. intermedius isolate, all of which were previously typed by 13 different methods (F. C. Tenover et al., J. Clin. Microbiol. 32:407-415, 1994). These 60 strains were divided into three groups of 20 strains each, with each group including internal controls. Two of the three groups (groups SB and SC) included 29 strains from four relatively well-defined outbreaks. The epidemiological relationships of the strains in the third group (group SA) were unclear. Fingerprints were established by Southern blotting with HaeIII-digested genomic DNA and a probe mixture consisting of DNA fragments corresponding to the S. aureus collagen adhesin (cna), fibronectin-binding protein (fnbA and fnbB), and beta-toxin (hlb) genes. An unambiguous fingerprint was obtained for all S. aureus isolates. No hybridization signal was observed with S. intermedius. Twenty-seven of the 29 related strains in the SB and SC groups were correctly identified as belonging to one of the four epidemiologically related groups. Our protocol was less successful with respect to the exclusion of unrelated strains. Specifically, only 6 of 11 unrelated strains in the SB and SC groups had a fingerprint that was distinct by comparison to the fingerprints of the outbreak strains. Nevertheless, our protocol was relatively accurate by comparison to the accuracies of the other methods and was one of only six methods that accurately identified all of the repetitive strains included as internal controls.

Indexed as

Adhesins, BacterialGenes, BacterialGenome, BacterialSphingomyelin PhosphodiesteraseBacterial ProteinsBacterial ToxinsCarrier ProteinsDisease OutbreaksDNA FingerprintingEvaluation Studies as TopicHemolysin ProteinsHumansSpecies SpecificityStaphylococcal InfectionsStaphylococcus aureusAdhesins, Bacterialadhesin, Staphylococcus aureusBacterial ProteinsBacterial ToxinsCarrier Proteinsfibronectin-binding proteins, bacterialHemolysin Proteinshlb protein, Staphylococcus aureusSphingomyelin Phosphodiesterase

Identifiers

PMID9316886
PMCPMC229989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.